Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. OZURDEX (dexamethasone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

OZURDEX (dexamethasone)

Medicine - Posted on Dec 16 2024
Active substance (DCI)
  • dexaméthasone
history (6)
  • 9/25/24

    OZURDEX (dexaméthasone) - Non-infectious uveitis

    Summary of opinion Favourable opinion for maintenance of reimbursement in the treatment of adult patients with inflammation ...
    CAV :
    54321
    icône flèche
  • 7/7/21

    OZURDEX (dexamethasone) (OMD)

    Key points Favourable opinion for reimbursement only in the treatment of visual impairment due to diabetic macular oedema (D...
    CAV :
    54321
    icône flèche
  • 4/6/16

    OZURDEX (dexamethasone)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 4/29/15

    OZURDEX (dexamethasone), corticosteroid

    No clinical benefit demonstrated in the treatment of visual impairment secondary to diabetic macular oedema: - compared with...
    CAV :
    54321
    icône flèche
  • 9/19/12

    OZURDEX

    -
    CAV :
    54321
    icône flèche
  • 11/17/10

    OZURDEX

    -
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • S01BA01
Manufacturer
ABBVIE
Presentation

OZURDEX 700 microgrammes, implant intravitréen avec applicateur (code CIS : 67392081)
1 sachet aluminium de 1 implant avec applicateur (CIP : 34009 494 071 1 8)

All our publications
    Diabetes mellitus Drug therapy Eye diseases Pain - Inflammation Protheses and implants

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
DLk3T2W47QSbEB3V